Sökning: onr:"swepub:oai:gup.ub.gu.se/309559" >
Changes in HbA1c Be...
-
Albanese-O'Neill, A.Univ Florida, FL USA
(författare)
Changes in HbA1c Between 2011 and 2017 in Germany/Austria, Sweden, and the United States: A Lifespan Perspective
- Artikel/kapitelEngelska2022
Förlag, utgivningsår, omfång ...
-
Mary Ann Liebert Inc,2022
Nummerbeteckningar
-
LIBRIS-ID:oai:gup.ub.gu.se/309559
-
https://gup.ub.gu.se/publication/309559URI
-
https://doi.org/10.1089/dia.2021.0225DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-180495URI
Kompletterande språkuppgifter
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Funding Agencies|German Center for Diabetes Research (DZD) [82DZD14A02]; German Diabetes Association (DDG); German Robert Koch Institute (RKI); Diabetes Agenda 2000; Helmsley Charitable Trust
-
Aims: This study assessed hemoglobin A1c (HbA1c) across the lifespan in people with type 1 diabetes (T1D) in Germany/Austria, Sweden, and the United States between 2011 and 2017 to ascertain temporal and age-related trends. Methods: Data from the Diabetes-Patienten-Verlaufsdokumentation (DPV) (n = 25,651 in 2011, n = 29,442 in 2017); Swedish Pediatric Diabetes Quality Registry (SWEDIABKIDS)/National Diabetes Register (NDR), (n = 44,474 in 2011, n = 53,690 in 2017); and T1D Exchange (n = 16,198 in 2011, n = 17,087 in 2017) registries were analyzed by linear regression to compare mean HbA1c overall and by age group. Results: Controlling for age, sex, and T1D duration, HbA1c increased in the United States between 2011 and 2017, decreased in Sweden, and did not change in Germany/Austria. Controlling for sex and T1D duration, mean HbA1c decreased between 2011 and 2017 in all age cohorts in Sweden (P < 0.001). In the United States, HbA1c stayed the same for participants <6 years and 45 to <65 years and increased in all other age groups (P < 0.05). In Germany/Austria, HbA1c stayed the same for participants <6 to <13 years and 18 to <25 years; decreased for participants ages 13 to <18 years (P < 0.01); and increased for participants >= 25 years (P < 0.05). Conclusions: The comparison of international trends in HbA1c makes it possible to identify differences, explore underlying causes, and share quality improvement processes. National quality improvement initiatives are well accepted in Europe but have yet to be implemented systematically in the United States. However, disparities created by the lack of universal access to health care coverage, unequal access to diabetes technologies (e.g., continuous glucose monitoring) regardless of insurance status, and high out-of-pocket cost for the underinsured ultimately limit the potential of quality improvement initiatives.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Grimsmann, J. M.Univ Ulm, Germany; German Ctr Diabet Res DZD, Germany
(författare)
-
Svensson, Ann-Marie,1961Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Ctr Registers Reg Vastra Gotaland, Sweden; Univ Gothenburg, Sweden(Swepub:gu)xsannh
(författare)
-
Miller, K. M.Jaeb Ctr Hlth Res, FL USA
(författare)
-
Raile, K.Charite Univ Med Berlin, Germany
(författare)
-
Åkesson, KarinLinköpings universitet,Avdelningen för barns och kvinnors hälsa,Medicinska fakulteten,Cty Hosp Ryhov, Sweden(Swepub:liu)karak14
(författare)
-
Calhoun, P.Jaeb Ctr Hlth Res, FL USA
(författare)
-
Biesenbach, B.Kepler Univ, Austria
(författare)
-
Eeg-Olofsson, Katarina,1968Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine,Univ Gothenburg, Sweden(Swepub:gu)xeegka
(författare)
-
Holl, R. W.Univ Ulm, Germany; German Ctr Diabet Res DZD, Germany
(författare)
-
Maahs, D. M.Stanford Diabet Res Ctr, CA USA; Stanford Univ, CA USA
(författare)
-
Hanas, RagnarGothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences,NU Hosp Grp, Sweden; Univ Gothenburg, Sweden
(författare)
-
Univ Florida, FL USAUniv Ulm, Germany; German Ctr Diabet Res DZD, Germany
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Diabetes Technology & Therapeutics: Mary Ann Liebert Inc24:1, s. 32-411520-91561557-8593
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Albanese-O'Neill ...
-
Grimsmann, J. M.
-
Svensson, Ann-Ma ...
-
Miller, K. M.
-
Raile, K.
-
Åkesson, Karin
-
visa fler...
-
Calhoun, P.
-
Biesenbach, B.
-
Eeg-Olofsson, Ka ...
-
Holl, R. W.
-
Maahs, D. M.
-
Hanas, Ragnar
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
- Artiklar i publikationen
-
Diabetes Technol ...
- Av lärosätet
-
Göteborgs universitet
-
Linköpings universitet